nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—hypertension—type 2 diabetes mellitus	0.477	1	CtDrD
Bumetanide—CFTR—Glyburide—type 2 diabetes mellitus	0.132	0.483	CbGbCtD
Bumetanide—PTGS2—type 2 diabetes mellitus	0.0663	1	CbGaD
Bumetanide—SLCO1A2—Tolbutamide—type 2 diabetes mellitus	0.029	0.106	CbGbCtD
Bumetanide—SLC22A7—Glyburide—type 2 diabetes mellitus	0.0238	0.0871	CbGbCtD
Bumetanide—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0197	0.0724	CbGbCtD
Bumetanide—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0176	0.0645	CbGbCtD
Bumetanide—SLCO1A2—Glyburide—type 2 diabetes mellitus	0.0167	0.0611	CbGbCtD
Bumetanide—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.015	0.0549	CbGbCtD
Bumetanide—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0101	0.0371	CbGbCtD
Bumetanide—SLC22A6—Losartan—type 2 diabetes mellitus	0.00925	0.0339	CbGbCtD
Bumetanide—SLC12A5—peripheral nervous system—type 2 diabetes mellitus	0.00366	0.105	CbGeAlD
Bumetanide—SLC12A5—nerve—type 2 diabetes mellitus	0.00285	0.0815	CbGeAlD
Bumetanide—Indapamide—KCNQ1—type 2 diabetes mellitus	0.00136	0.511	CrCbGaD
Bumetanide—SLC12A5—retina—type 2 diabetes mellitus	0.00118	0.0338	CbGeAlD
Bumetanide—SLC12A4—retina—type 2 diabetes mellitus	0.000981	0.028	CbGeAlD
Bumetanide—CFTR—islet of Langerhans—type 2 diabetes mellitus	0.000902	0.0258	CbGeAlD
Bumetanide—PTGS2—leg—type 2 diabetes mellitus	0.000831	0.0237	CbGeAlD
Bumetanide—SLC12A4—cardiovascular system—type 2 diabetes mellitus	0.00083	0.0237	CbGeAlD
Bumetanide—SLC12A2—islet of Langerhans—type 2 diabetes mellitus	0.000792	0.0226	CbGeAlD
Bumetanide—CA9—islet of Langerhans—type 2 diabetes mellitus	0.00078	0.0223	CbGeAlD
Bumetanide—PTGS2—hindlimb—type 2 diabetes mellitus	0.000742	0.0212	CbGeAlD
Bumetanide—CA4—nerve—type 2 diabetes mellitus	0.000737	0.0211	CbGeAlD
Bumetanide—SLC12A4—adipose tissue—type 2 diabetes mellitus	0.000732	0.0209	CbGeAlD
Bumetanide—CFTR—kidney—type 2 diabetes mellitus	0.000638	0.0182	CbGeAlD
Bumetanide—SLC12A2—nephron tubule—type 2 diabetes mellitus	0.000638	0.0182	CbGeAlD
Bumetanide—CFTR—pancreas—type 2 diabetes mellitus	0.000634	0.0181	CbGeAlD
Bumetanide—CA7—kidney—type 2 diabetes mellitus	0.000628	0.0179	CbGeAlD
Bumetanide—CA5A—liver—type 2 diabetes mellitus	0.000597	0.0171	CbGeAlD
Bumetanide—SLC12A2—cardiovascular system—type 2 diabetes mellitus	0.000573	0.0164	CbGeAlD
Bumetanide—SLC12A2—kidney—type 2 diabetes mellitus	0.00056	0.016	CbGeAlD
Bumetanide—SLC12A2—pancreas—type 2 diabetes mellitus	0.000557	0.0159	CbGeAlD
Bumetanide—SLC22A11—nephron tubule—type 2 diabetes mellitus	0.00055	0.0157	CbGeAlD
Bumetanide—SLC12A2—cortex of kidney—type 2 diabetes mellitus	0.000546	0.0156	CbGeAlD
Bumetanide—SLC12A1—nephron tubule—type 2 diabetes mellitus	0.000535	0.0153	CbGeAlD
Bumetanide—SLC10A1—kidney—type 2 diabetes mellitus	0.000529	0.0151	CbGeAlD
Bumetanide—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.000518	0.0148	CbGeAlD
Bumetanide—SLC12A4—liver—type 2 diabetes mellitus	0.000513	0.0147	CbGeAlD
Bumetanide—SLC12A2—adipose tissue—type 2 diabetes mellitus	0.000505	0.0144	CbGeAlD
Bumetanide—SLC22A11—kidney—type 2 diabetes mellitus	0.000483	0.0138	CbGeAlD
Bumetanide—SLC22A7—kidney—type 2 diabetes mellitus	0.000472	0.0135	CbGeAlD
Bumetanide—SLC22A11—cortex of kidney—type 2 diabetes mellitus	0.000471	0.0135	CbGeAlD
Bumetanide—SLC12A1—kidney—type 2 diabetes mellitus	0.00047	0.0134	CbGeAlD
Bumetanide—SLC22A7—cortex of kidney—type 2 diabetes mellitus	0.00046	0.0131	CbGeAlD
Bumetanide—SLC12A1—cortex of kidney—type 2 diabetes mellitus	0.000458	0.0131	CbGeAlD
Bumetanide—PTGS2—artery—type 2 diabetes mellitus	0.000455	0.013	CbGeAlD
Bumetanide—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.000444	0.0127	CbGeAlD
Bumetanide—CA12—kidney—type 2 diabetes mellitus	0.000408	0.0117	CbGeAlD
Bumetanide—CFTR—liver—type 2 diabetes mellitus	0.000403	0.0115	CbGeAlD
Bumetanide—PTGS2—endothelium—type 2 diabetes mellitus	0.000384	0.011	CbGeAlD
Bumetanide—CA5B—cardiovascular system—type 2 diabetes mellitus	0.000374	0.0107	CbGeAlD
Bumetanide—CA5B—pancreas—type 2 diabetes mellitus	0.000364	0.0104	CbGeAlD
Bumetanide—CA4—islet of Langerhans—type 2 diabetes mellitus	0.000357	0.0102	CbGeAlD
Bumetanide—SLC12A2—liver—type 2 diabetes mellitus	0.000354	0.0101	CbGeAlD
Bumetanide—Furosemide—ABCC2—type 2 diabetes mellitus	0.000354	0.133	CrCbGaD
Bumetanide—SLC10A1—liver—type 2 diabetes mellitus	0.000335	0.00956	CbGeAlD
Bumetanide—CA14—liver—type 2 diabetes mellitus	0.000331	0.00945	CbGeAlD
Bumetanide—CA5B—adipose tissue—type 2 diabetes mellitus	0.00033	0.00943	CbGeAlD
Bumetanide—Tamsulosin—ADRA2A—type 2 diabetes mellitus	0.000321	0.12	CrCbGaD
Bumetanide—SLC22A8—nephron tubule—type 2 diabetes mellitus	0.00031	0.00887	CbGeAlD
Bumetanide—SLC22A11—liver—type 2 diabetes mellitus	0.000306	0.00873	CbGeAlD
Bumetanide—SLC22A7—liver—type 2 diabetes mellitus	0.000298	0.00852	CbGeAlD
Bumetanide—CA4—nephron tubule—type 2 diabetes mellitus	0.000288	0.00821	CbGeAlD
Bumetanide—SLCO1A2—kidney—type 2 diabetes mellitus	0.000286	0.00816	CbGeAlD
Bumetanide—SLC22A8—kidney—type 2 diabetes mellitus	0.000273	0.00779	CbGeAlD
Bumetanide—SLC22A8—cortex of kidney—type 2 diabetes mellitus	0.000266	0.00759	CbGeAlD
Bumetanide—CA4—cardiovascular system—type 2 diabetes mellitus	0.000258	0.00738	CbGeAlD
Bumetanide—CA4—kidney—type 2 diabetes mellitus	0.000253	0.00722	CbGeAlD
Bumetanide—CA4—cortex of kidney—type 2 diabetes mellitus	0.000246	0.00703	CbGeAlD
Bumetanide—CA4—adipose tissue—type 2 diabetes mellitus	0.000228	0.00651	CbGeAlD
Bumetanide—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000219	0.00625	CbGeAlD
Bumetanide—SLCO1A2—liver—type 2 diabetes mellitus	0.000181	0.00516	CbGeAlD
Bumetanide—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000173	0.00202	CcSEcCtD
Bumetanide—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000171	0.00201	CcSEcCtD
Bumetanide—Hyperglycaemia—Irbesartan—type 2 diabetes mellitus	0.00017	0.00199	CcSEcCtD
Bumetanide—Nausea—Acarbose—type 2 diabetes mellitus	0.000169	0.00198	CcSEcCtD
Bumetanide—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.000168	0.00198	CcSEcCtD
Bumetanide—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000168	0.00197	CcSEcCtD
Bumetanide—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000166	0.00194	CcSEcCtD
Bumetanide—Renal failure—Irbesartan—type 2 diabetes mellitus	0.000165	0.00193	CcSEcCtD
Bumetanide—Blood creatinine increased—Ramipril—type 2 diabetes mellitus	0.000165	0.00193	CcSEcCtD
Bumetanide—Nausea—Nateglinide—type 2 diabetes mellitus	0.000163	0.00191	CcSEcCtD
Bumetanide—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000162	0.0019	CcSEcCtD
Bumetanide—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.000162	0.0019	CcSEcCtD
Bumetanide—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000161	0.00189	CcSEcCtD
Bumetanide—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.00016	0.00188	CcSEcCtD
Bumetanide—Hyperglycaemia—Losartan—type 2 diabetes mellitus	0.00016	0.00187	CcSEcCtD
Bumetanide—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000158	0.00186	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Ramipril—type 2 diabetes mellitus	0.000158	0.00186	CcSEcCtD
Bumetanide—Cramp muscle—Ramipril—type 2 diabetes mellitus	0.000158	0.00186	CcSEcCtD
Bumetanide—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000158	0.00452	CbGeAlD
Bumetanide—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000158	0.00185	CcSEcCtD
Bumetanide—Arthralgia—Glyburide—type 2 diabetes mellitus	0.000157	0.00185	CcSEcCtD
Bumetanide—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000157	0.00185	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	0.000157	0.00184	CcSEcCtD
Bumetanide—Urticaria—Glipizide—type 2 diabetes mellitus	0.000156	0.00183	CcSEcCtD
Bumetanide—Renal failure—Losartan—type 2 diabetes mellitus	0.000155	0.00182	CcSEcCtD
Bumetanide—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000155	0.00182	CcSEcCtD
Bumetanide—PTGS2—kidney—type 2 diabetes mellitus	0.000155	0.00442	CbGeAlD
Bumetanide—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000154	0.00181	CcSEcCtD
Bumetanide—PTGS2—pancreas—type 2 diabetes mellitus	0.000154	0.00439	CbGeAlD
Bumetanide—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000153	0.0018	CcSEcCtD
Bumetanide—Sweating—Losartan—type 2 diabetes mellitus	0.000151	0.00178	CcSEcCtD
Bumetanide—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000151	0.00177	CcSEcCtD
Bumetanide—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.00015	0.00176	CcSEcCtD
Bumetanide—Rash—Repaglinide—type 2 diabetes mellitus	0.000149	0.00175	CcSEcCtD
Bumetanide—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000149	0.00175	CcSEcCtD
Bumetanide—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000149	0.00175	CcSEcCtD
Bumetanide—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000149	0.00175	CcSEcCtD
Bumetanide—Pancreatitis—Ramipril—type 2 diabetes mellitus	0.000149	0.00175	CcSEcCtD
Bumetanide—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000149	0.00174	CcSEcCtD
Bumetanide—Headache—Repaglinide—type 2 diabetes mellitus	0.000148	0.00174	CcSEcCtD
Bumetanide—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000148	0.00174	CcSEcCtD
Bumetanide—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000148	0.00173	CcSEcCtD
Bumetanide—Tamsulosin—CYP3A4—type 2 diabetes mellitus	0.000148	0.0554	CrCbGaD
Bumetanide—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000147	0.00172	CcSEcCtD
Bumetanide—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000146	0.00171	CcSEcCtD
Bumetanide—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.000146	0.00171	CcSEcCtD
Bumetanide—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000145	0.00171	CcSEcCtD
Bumetanide—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000145	0.0017	CcSEcCtD
Bumetanide—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000145	0.0017	CcSEcCtD
Bumetanide—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000145	0.0017	CcSEcCtD
Bumetanide—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000144	0.00169	CcSEcCtD
Bumetanide—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000142	0.00167	CcSEcCtD
Bumetanide—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000141	0.00166	CcSEcCtD
Bumetanide—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000141	0.00166	CcSEcCtD
Bumetanide—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000141	0.00166	CcSEcCtD
Bumetanide—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000141	0.00166	CcSEcCtD
Bumetanide—Hypotension—Glyburide—type 2 diabetes mellitus	0.000141	0.00165	CcSEcCtD
Bumetanide—Nausea—Repaglinide—type 2 diabetes mellitus	0.000141	0.00165	CcSEcCtD
Bumetanide—Asthenia—Glipizide—type 2 diabetes mellitus	0.000141	0.00165	CcSEcCtD
Bumetanide—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00014	0.00165	CcSEcCtD
Bumetanide—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000139	0.00398	CbGeAlD
Bumetanide—Pruritus—Glipizide—type 2 diabetes mellitus	0.000139	0.00163	CcSEcCtD
Bumetanide—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000138	0.00162	CcSEcCtD
Bumetanide—Vertigo—Valsartan—type 2 diabetes mellitus	0.000137	0.00161	CcSEcCtD
Bumetanide—Furosemide—ALB—type 2 diabetes mellitus	0.000137	0.0513	CrCbGaD
Bumetanide—Vertigo—Orlistat—type 2 diabetes mellitus	0.000135	0.00159	CcSEcCtD
Bumetanide—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000135	0.00158	CcSEcCtD
Bumetanide—Indapamide—CYP3A4—type 2 diabetes mellitus	0.000135	0.0507	CrCbGaD
Bumetanide—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000135	0.00158	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000134	0.00157	CcSEcCtD
Bumetanide—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000134	0.00157	CcSEcCtD
Bumetanide—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000134	0.00157	CcSEcCtD
Bumetanide—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000134	0.00157	CcSEcCtD
Bumetanide—Renal failure—Ramipril—type 2 diabetes mellitus	0.000133	0.00156	CcSEcCtD
Bumetanide—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000133	0.00156	CcSEcCtD
Bumetanide—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000133	0.00156	CcSEcCtD
Bumetanide—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000131	0.00154	CcSEcCtD
Bumetanide—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000131	0.00154	CcSEcCtD
Bumetanide—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000131	0.00154	CcSEcCtD
Bumetanide—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000131	0.00154	CcSEcCtD
Bumetanide—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000131	0.00153	CcSEcCtD
Bumetanide—Chest pain—Valsartan—type 2 diabetes mellitus	0.00013	0.00152	CcSEcCtD
Bumetanide—Arthralgia—Valsartan—type 2 diabetes mellitus	0.00013	0.00152	CcSEcCtD
Bumetanide—Sweating—Ramipril—type 2 diabetes mellitus	0.00013	0.00152	CcSEcCtD
Bumetanide—Dizziness—Glipizide—type 2 diabetes mellitus	0.00013	0.00152	CcSEcCtD
Bumetanide—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000129	0.00152	CcSEcCtD
Bumetanide—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000129	0.00151	CcSEcCtD
Bumetanide—Chest pain—Orlistat—type 2 diabetes mellitus	0.000128	0.00151	CcSEcCtD
Bumetanide—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000127	0.00149	CcSEcCtD
Bumetanide—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000127	0.00149	CcSEcCtD
Bumetanide—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000126	0.00148	CcSEcCtD
Bumetanide—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000126	0.00147	CcSEcCtD
Bumetanide—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000125	0.00147	CcSEcCtD
Bumetanide—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000125	0.00146	CcSEcCtD
Bumetanide—Vomiting—Glipizide—type 2 diabetes mellitus	0.000125	0.00146	CcSEcCtD
Bumetanide—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000124	0.00146	CcSEcCtD
Bumetanide—Rash—Glipizide—type 2 diabetes mellitus	0.000124	0.00145	CcSEcCtD
Bumetanide—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000124	0.00145	CcSEcCtD
Bumetanide—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000123	0.00145	CcSEcCtD
Bumetanide—Headache—Glipizide—type 2 diabetes mellitus	0.000123	0.00144	CcSEcCtD
Bumetanide—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000122	0.00143	CcSEcCtD
Bumetanide—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000121	0.00142	CcSEcCtD
Bumetanide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000121	0.00142	CcSEcCtD
Bumetanide—Urticaria—Glyburide—type 2 diabetes mellitus	0.00012	0.00141	CcSEcCtD
Bumetanide—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000119	0.0014	CcSEcCtD
Bumetanide—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000119	0.0014	CcSEcCtD
Bumetanide—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000119	0.00139	CcSEcCtD
Bumetanide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000118	0.00139	CcSEcCtD
Bumetanide—Chest pain—Metformin—type 2 diabetes mellitus	0.000118	0.00139	CcSEcCtD
Bumetanide—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000118	0.00138	CcSEcCtD
Bumetanide—Headache—Pioglitazone—type 2 diabetes mellitus	0.000118	0.00138	CcSEcCtD
Bumetanide—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000117	0.00138	CcSEcCtD
Bumetanide—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000117	0.00137	CcSEcCtD
Bumetanide—Nausea—Glipizide—type 2 diabetes mellitus	0.000116	0.00137	CcSEcCtD
Bumetanide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000116	0.00136	CcSEcCtD
Bumetanide—Hypotension—Valsartan—type 2 diabetes mellitus	0.000116	0.00136	CcSEcCtD
Bumetanide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000116	0.00136	CcSEcCtD
Bumetanide—Rash—Glimepiride—type 2 diabetes mellitus	0.000115	0.00135	CcSEcCtD
Bumetanide—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000115	0.00135	CcSEcCtD
Bumetanide—Rash—Sitagliptin—type 2 diabetes mellitus	0.000115	0.00135	CcSEcCtD
Bumetanide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000115	0.00135	CcSEcCtD
Bumetanide—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000115	0.00135	CcSEcCtD
Bumetanide—Headache—Glimepiride—type 2 diabetes mellitus	0.000115	0.00134	CcSEcCtD
Bumetanide—Headache—Sitagliptin—type 2 diabetes mellitus	0.000114	0.00134	CcSEcCtD
Bumetanide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000113	0.00133	CcSEcCtD
Bumetanide—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000112	0.00131	CcSEcCtD
Bumetanide—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000112	0.00131	CcSEcCtD
Bumetanide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000111	0.0013	CcSEcCtD
Bumetanide—Vertigo—Losartan—type 2 diabetes mellitus	0.000111	0.0013	CcSEcCtD
Bumetanide—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000111	0.0013	CcSEcCtD
Bumetanide—Leukopenia—Losartan—type 2 diabetes mellitus	0.00011	0.0013	CcSEcCtD
Bumetanide—Fenoprofen—PTGS2—type 2 diabetes mellitus	0.00011	0.0413	CrCbGaD
Bumetanide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.00011	0.00129	CcSEcCtD
Bumetanide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000109	0.00128	CcSEcCtD
Bumetanide—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000109	0.00128	CcSEcCtD
Bumetanide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000109	0.00128	CcSEcCtD
Bumetanide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000108	0.00127	CcSEcCtD
Bumetanide—Asthenia—Glyburide—type 2 diabetes mellitus	0.000108	0.00127	CcSEcCtD
Bumetanide—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000108	0.00126	CcSEcCtD
Bumetanide—Fatigue—Valsartan—type 2 diabetes mellitus	0.000107	0.00126	CcSEcCtD
Bumetanide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000107	0.00126	CcSEcCtD
Bumetanide—Pruritus—Glyburide—type 2 diabetes mellitus	0.000107	0.00125	CcSEcCtD
Bumetanide—Fatigue—Orlistat—type 2 diabetes mellitus	0.000106	0.00124	CcSEcCtD
Bumetanide—Hypotension—Metformin—type 2 diabetes mellitus	0.000106	0.00124	CcSEcCtD
Bumetanide—Arthralgia—Losartan—type 2 diabetes mellitus	0.000105	0.00123	CcSEcCtD
Bumetanide—Chest pain—Losartan—type 2 diabetes mellitus	0.000105	0.00123	CcSEcCtD
Bumetanide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000105	0.00123	CcSEcCtD
Bumetanide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000105	0.00123	CcSEcCtD
Bumetanide—Rash—Bromocriptine—type 2 diabetes mellitus	0.000104	0.00122	CcSEcCtD
Bumetanide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000104	0.00122	CcSEcCtD
Bumetanide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000103	0.00121	CcSEcCtD
Bumetanide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000103	0.00121	CcSEcCtD
Bumetanide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000103	0.00121	CcSEcCtD
Bumetanide—Dry mouth—Losartan—type 2 diabetes mellitus	0.000103	0.00121	CcSEcCtD
Bumetanide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000102	0.00119	CcSEcCtD
Bumetanide—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000102	0.00119	CcSEcCtD
Bumetanide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000101	0.00118	CcSEcCtD
Bumetanide—Hypotension—Irbesartan—type 2 diabetes mellitus	0.0001	0.00117	CcSEcCtD
Bumetanide—Urticaria—Valsartan—type 2 diabetes mellitus	9.89e-05	0.00116	CcSEcCtD
Bumetanide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	9.86e-05	0.00116	CcSEcCtD
Bumetanide—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.84e-05	0.00115	CcSEcCtD
Bumetanide—Nausea—Bromocriptine—type 2 diabetes mellitus	9.81e-05	0.00115	CcSEcCtD
Bumetanide—Fenoprofen—ALB—type 2 diabetes mellitus	9.8e-05	0.0368	CrCbGaD
Bumetanide—PTGS2—liver—type 2 diabetes mellitus	9.78e-05	0.00279	CbGeAlD
Bumetanide—Fatigue—Metformin—type 2 diabetes mellitus	9.78e-05	0.00115	CcSEcCtD
Bumetanide—Urticaria—Orlistat—type 2 diabetes mellitus	9.77e-05	0.00115	CcSEcCtD
Bumetanide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	9.73e-05	0.00114	CcSEcCtD
Bumetanide—Abdominal pain—Orlistat—type 2 diabetes mellitus	9.73e-05	0.00114	CcSEcCtD
Bumetanide—Asthenia—Gliclazide—type 2 diabetes mellitus	9.72e-05	0.00114	CcSEcCtD
Bumetanide—Vomiting—Glyburide—type 2 diabetes mellitus	9.6e-05	0.00113	CcSEcCtD
Bumetanide—Pruritus—Gliclazide—type 2 diabetes mellitus	9.59e-05	0.00112	CcSEcCtD
Bumetanide—Rash—Glyburide—type 2 diabetes mellitus	9.52e-05	0.00112	CcSEcCtD
Bumetanide—Dermatitis—Glyburide—type 2 diabetes mellitus	9.51e-05	0.00112	CcSEcCtD
Bumetanide—Vertigo—Ramipril—type 2 diabetes mellitus	9.51e-05	0.00112	CcSEcCtD
Bumetanide—Leukopenia—Ramipril—type 2 diabetes mellitus	9.47e-05	0.00111	CcSEcCtD
Bumetanide—Headache—Glyburide—type 2 diabetes mellitus	9.45e-05	0.00111	CcSEcCtD
Bumetanide—Hypotension—Losartan—type 2 diabetes mellitus	9.41e-05	0.0011	CcSEcCtD
Bumetanide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.27e-05	0.00109	CcSEcCtD
Bumetanide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	9.27e-05	0.00109	CcSEcCtD
Bumetanide—Fatigue—Irbesartan—type 2 diabetes mellitus	9.23e-05	0.00108	CcSEcCtD
Bumetanide—Urticaria—Metformin—type 2 diabetes mellitus	9.01e-05	0.00106	CcSEcCtD
Bumetanide—Arthralgia—Ramipril—type 2 diabetes mellitus	9.01e-05	0.00106	CcSEcCtD
Bumetanide—Chest pain—Ramipril—type 2 diabetes mellitus	9.01e-05	0.00106	CcSEcCtD
Bumetanide—Nausea—Glyburide—type 2 diabetes mellitus	8.96e-05	0.00105	CcSEcCtD
Bumetanide—Abdominal pain—Metformin—type 2 diabetes mellitus	8.96e-05	0.00105	CcSEcCtD
Bumetanide—Dizziness—Gliclazide—type 2 diabetes mellitus	8.96e-05	0.00105	CcSEcCtD
Bumetanide—Asthenia—Valsartan—type 2 diabetes mellitus	8.93e-05	0.00105	CcSEcCtD
Bumetanide—Asthenia—Orlistat—type 2 diabetes mellitus	8.83e-05	0.00104	CcSEcCtD
Bumetanide—Pruritus—Valsartan—type 2 diabetes mellitus	8.81e-05	0.00103	CcSEcCtD
Bumetanide—Dry mouth—Ramipril—type 2 diabetes mellitus	8.81e-05	0.00103	CcSEcCtD
Bumetanide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.75e-05	0.00103	CcSEcCtD
Bumetanide—Pruritus—Orlistat—type 2 diabetes mellitus	8.7e-05	0.00102	CcSEcCtD
Bumetanide—Fatigue—Losartan—type 2 diabetes mellitus	8.68e-05	0.00102	CcSEcCtD
Bumetanide—Vomiting—Gliclazide—type 2 diabetes mellitus	8.62e-05	0.00101	CcSEcCtD
Bumetanide—Rash—Gliclazide—type 2 diabetes mellitus	8.54e-05	0.001	CcSEcCtD
Bumetanide—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.54e-05	0.001	CcSEcCtD
Bumetanide—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.52e-05	0.000999	CcSEcCtD
Bumetanide—Urticaria—Irbesartan—type 2 diabetes mellitus	8.5e-05	0.000997	CcSEcCtD
Bumetanide—Headache—Gliclazide—type 2 diabetes mellitus	8.49e-05	0.000996	CcSEcCtD
Bumetanide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.46e-05	0.000992	CcSEcCtD
Bumetanide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	8.45e-05	0.000992	CcSEcCtD
Bumetanide—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.42e-05	0.000987	CcSEcCtD
Bumetanide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	8.35e-05	0.000979	CcSEcCtD
Bumetanide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.23e-05	0.000966	CcSEcCtD
Bumetanide—Dizziness—Valsartan—type 2 diabetes mellitus	8.23e-05	0.000966	CcSEcCtD
Bumetanide—Dizziness—Orlistat—type 2 diabetes mellitus	8.14e-05	0.000954	CcSEcCtD
Bumetanide—Asthenia—Metformin—type 2 diabetes mellitus	8.14e-05	0.000954	CcSEcCtD
Bumetanide—Hypotension—Ramipril—type 2 diabetes mellitus	8.07e-05	0.000946	CcSEcCtD
Bumetanide—Nausea—Gliclazide—type 2 diabetes mellitus	8.05e-05	0.000944	CcSEcCtD
Bumetanide—Pruritus—Metformin—type 2 diabetes mellitus	8.02e-05	0.000941	CcSEcCtD
Bumetanide—Urticaria—Losartan—type 2 diabetes mellitus	8e-05	0.000938	CcSEcCtD
Bumetanide—Abdominal pain—Losartan—type 2 diabetes mellitus	7.96e-05	0.000934	CcSEcCtD
Bumetanide—Vomiting—Valsartan—type 2 diabetes mellitus	7.92e-05	0.000929	CcSEcCtD
Bumetanide—Rash—Valsartan—type 2 diabetes mellitus	7.85e-05	0.000921	CcSEcCtD
Bumetanide—Dermatitis—Valsartan—type 2 diabetes mellitus	7.84e-05	0.00092	CcSEcCtD
Bumetanide—Vomiting—Orlistat—type 2 diabetes mellitus	7.82e-05	0.000918	CcSEcCtD
Bumetanide—Headache—Valsartan—type 2 diabetes mellitus	7.8e-05	0.000915	CcSEcCtD
Bumetanide—Diarrhoea—Metformin—type 2 diabetes mellitus	7.76e-05	0.00091	CcSEcCtD
Bumetanide—Rash—Orlistat—type 2 diabetes mellitus	7.76e-05	0.00091	CcSEcCtD
Bumetanide—Dermatitis—Orlistat—type 2 diabetes mellitus	7.75e-05	0.000909	CcSEcCtD
Bumetanide—Headache—Orlistat—type 2 diabetes mellitus	7.71e-05	0.000904	CcSEcCtD
Bumetanide—Asthenia—Irbesartan—type 2 diabetes mellitus	7.68e-05	0.000901	CcSEcCtD
Bumetanide—Pruritus—Irbesartan—type 2 diabetes mellitus	7.57e-05	0.000888	CcSEcCtD
Bumetanide—Dizziness—Metformin—type 2 diabetes mellitus	7.5e-05	0.00088	CcSEcCtD
Bumetanide—Fatigue—Ramipril—type 2 diabetes mellitus	7.44e-05	0.000873	CcSEcCtD
Bumetanide—Nausea—Valsartan—type 2 diabetes mellitus	7.4e-05	0.000868	CcSEcCtD
Bumetanide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.32e-05	0.000859	CcSEcCtD
Bumetanide—Nausea—Orlistat—type 2 diabetes mellitus	7.31e-05	0.000857	CcSEcCtD
Bumetanide—Asthenia—Losartan—type 2 diabetes mellitus	7.22e-05	0.000848	CcSEcCtD
Bumetanide—Vomiting—Metformin—type 2 diabetes mellitus	7.21e-05	0.000846	CcSEcCtD
Bumetanide—Rash—Metformin—type 2 diabetes mellitus	7.15e-05	0.000839	CcSEcCtD
Bumetanide—Dermatitis—Metformin—type 2 diabetes mellitus	7.14e-05	0.000838	CcSEcCtD
Bumetanide—Pruritus—Losartan—type 2 diabetes mellitus	7.12e-05	0.000836	CcSEcCtD
Bumetanide—Headache—Metformin—type 2 diabetes mellitus	7.1e-05	0.000833	CcSEcCtD
Bumetanide—Dizziness—Irbesartan—type 2 diabetes mellitus	7.08e-05	0.00083	CcSEcCtD
Bumetanide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.06e-05	0.000828	CcSEcCtD
Bumetanide—Diarrhoea—Losartan—type 2 diabetes mellitus	6.89e-05	0.000808	CcSEcCtD
Bumetanide—Urticaria—Ramipril—type 2 diabetes mellitus	6.86e-05	0.000805	CcSEcCtD
Bumetanide—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.83e-05	0.000801	CcSEcCtD
Bumetanide—Vomiting—Irbesartan—type 2 diabetes mellitus	6.8e-05	0.000798	CcSEcCtD
Bumetanide—Rash—Irbesartan—type 2 diabetes mellitus	6.75e-05	0.000791	CcSEcCtD
Bumetanide—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.74e-05	0.000791	CcSEcCtD
Bumetanide—Nausea—Metformin—type 2 diabetes mellitus	6.73e-05	0.00079	CcSEcCtD
Bumetanide—Headache—Irbesartan—type 2 diabetes mellitus	6.7e-05	0.000786	CcSEcCtD
Bumetanide—Dizziness—Losartan—type 2 diabetes mellitus	6.66e-05	0.000781	CcSEcCtD
Bumetanide—Vomiting—Losartan—type 2 diabetes mellitus	6.4e-05	0.000751	CcSEcCtD
Bumetanide—Nausea—Irbesartan—type 2 diabetes mellitus	6.36e-05	0.000746	CcSEcCtD
Bumetanide—Rash—Losartan—type 2 diabetes mellitus	6.35e-05	0.000745	CcSEcCtD
Bumetanide—Dermatitis—Losartan—type 2 diabetes mellitus	6.34e-05	0.000744	CcSEcCtD
Bumetanide—Headache—Losartan—type 2 diabetes mellitus	6.31e-05	0.00074	CcSEcCtD
Bumetanide—Asthenia—Ramipril—type 2 diabetes mellitus	6.2e-05	0.000727	CcSEcCtD
Bumetanide—Pruritus—Ramipril—type 2 diabetes mellitus	6.11e-05	0.000717	CcSEcCtD
Bumetanide—Nausea—Losartan—type 2 diabetes mellitus	5.98e-05	0.000702	CcSEcCtD
Bumetanide—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.91e-05	0.000693	CcSEcCtD
Bumetanide—Dizziness—Ramipril—type 2 diabetes mellitus	5.71e-05	0.00067	CcSEcCtD
Bumetanide—Vomiting—Ramipril—type 2 diabetes mellitus	5.49e-05	0.000644	CcSEcCtD
Bumetanide—Rash—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000639	CcSEcCtD
Bumetanide—Dermatitis—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000638	CcSEcCtD
Bumetanide—Headache—Ramipril—type 2 diabetes mellitus	5.41e-05	0.000635	CcSEcCtD
Bumetanide—Nausea—Ramipril—type 2 diabetes mellitus	5.13e-05	0.000602	CcSEcCtD
Bumetanide—CA7—Metabolism—ALB—type 2 diabetes mellitus	6.9e-06	0.000113	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ALB—type 2 diabetes mellitus	6.9e-06	0.000113	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GNB3—type 2 diabetes mellitus	6.89e-06	0.000112	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.89e-06	0.000112	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	6.87e-06	0.000112	CbGpPWpGaD
Bumetanide—CA9—Metabolism—HMOX1—type 2 diabetes mellitus	6.86e-06	0.000112	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PPARA—type 2 diabetes mellitus	6.85e-06	0.000112	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CALM1—type 2 diabetes mellitus	6.84e-06	0.000112	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—APOE—type 2 diabetes mellitus	6.82e-06	0.000111	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CAT—type 2 diabetes mellitus	6.76e-06	0.00011	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—APOA1—type 2 diabetes mellitus	6.74e-06	0.00011	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CPT1A—type 2 diabetes mellitus	6.73e-06	0.00011	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—MTR—type 2 diabetes mellitus	6.73e-06	0.00011	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	6.66e-06	0.000109	CbGpPWpGaD
Bumetanide—CA4—Metabolism—AGT—type 2 diabetes mellitus	6.64e-06	0.000108	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PTGS2—type 2 diabetes mellitus	6.63e-06	0.000108	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—NAMPT—type 2 diabetes mellitus	6.6e-06	0.000108	CbGpPWpGaD
Bumetanide—CA7—Metabolism—NOS3—type 2 diabetes mellitus	6.6e-06	0.000108	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PIK3R1—type 2 diabetes mellitus	6.6e-06	0.000108	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PIK3R1—type 2 diabetes mellitus	6.6e-06	0.000108	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—NOS3—type 2 diabetes mellitus	6.6e-06	0.000108	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PCK1—type 2 diabetes mellitus	6.58e-06	0.000108	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HSD17B3—type 2 diabetes mellitus	6.58e-06	0.000107	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—STAR—type 2 diabetes mellitus	6.58e-06	0.000107	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ACACA—type 2 diabetes mellitus	6.58e-06	0.000107	CbGpPWpGaD
Bumetanide—CA9—Metabolism—APOB—type 2 diabetes mellitus	6.57e-06	0.000107	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.56e-06	0.000107	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GCK—type 2 diabetes mellitus	6.56e-06	0.000107	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—HBA1—type 2 diabetes mellitus	6.56e-06	0.000107	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—LIPC—type 2 diabetes mellitus	6.56e-06	0.000107	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CALM1—type 2 diabetes mellitus	6.53e-06	0.000107	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	6.52e-06	0.000106	CbGpPWpGaD
Bumetanide—CA4—Metabolism—APOE—type 2 diabetes mellitus	6.5e-06	0.000106	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	6.48e-06	0.000106	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PTGS2—type 2 diabetes mellitus	6.46e-06	0.000106	CbGpPWpGaD
Bumetanide—CA4—Metabolism—APOA1—type 2 diabetes mellitus	6.43e-06	0.000105	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TLE4—type 2 diabetes mellitus	6.4e-06	0.000105	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	6.4e-06	0.000105	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GSTM1—type 2 diabetes mellitus	6.39e-06	0.000104	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ALB—type 2 diabetes mellitus	6.39e-06	0.000104	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CETP—type 2 diabetes mellitus	6.33e-06	0.000103	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.32e-06	0.000103	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CBS—type 2 diabetes mellitus	6.31e-06	0.000103	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ABCC8—type 2 diabetes mellitus	6.31e-06	0.000103	CbGpPWpGaD
Bumetanide—CA9—Metabolism—LPL—type 2 diabetes mellitus	6.27e-06	0.000102	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HK1—type 2 diabetes mellitus	6.16e-06	0.000101	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ADCY5—type 2 diabetes mellitus	6.14e-06	0.0001	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GPX1—type 2 diabetes mellitus	6.12e-06	9.99e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PIK3R1—type 2 diabetes mellitus	6.11e-06	9.98e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—NOS3—type 2 diabetes mellitus	6.11e-06	9.98e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—COX2—type 2 diabetes mellitus	6.07e-06	9.92e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SLC5A2—type 2 diabetes mellitus	6.07e-06	9.92e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	6.04e-06	9.86e-05	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PTGS2—type 2 diabetes mellitus	6.03e-06	9.85e-05	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PTGS2—type 2 diabetes mellitus	6.03e-06	9.85e-05	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL6—type 2 diabetes mellitus	5.98e-06	9.76e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NCOA6—type 2 diabetes mellitus	5.96e-06	9.74e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	5.96e-06	9.74e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CD36—type 2 diabetes mellitus	5.96e-06	9.73e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—GCKR—type 2 diabetes mellitus	5.95e-06	9.72e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PPARG—type 2 diabetes mellitus	5.94e-06	9.7e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.9e-06	9.64e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PPP2CA—type 2 diabetes mellitus	5.88e-06	9.61e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SREBF1—type 2 diabetes mellitus	5.88e-06	9.61e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PSMD6—type 2 diabetes mellitus	5.88e-06	9.61e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SNAP25—type 2 diabetes mellitus	5.88e-06	9.61e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	5.88e-06	9.6e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—UCP2—type 2 diabetes mellitus	5.86e-06	9.58e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—UCP3—type 2 diabetes mellitus	5.86e-06	9.58e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HSD11B1—type 2 diabetes mellitus	5.86e-06	9.58e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—INS—type 2 diabetes mellitus	5.82e-06	9.51e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CTGF—type 2 diabetes mellitus	5.77e-06	9.43e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—HMGCR—type 2 diabetes mellitus	5.72e-06	9.35e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ALDOB—type 2 diabetes mellitus	5.71e-06	9.32e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	5.68e-06	9.28e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PPARG—type 2 diabetes mellitus	5.67e-06	9.25e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—MTHFR—type 2 diabetes mellitus	5.65e-06	9.22e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.64e-06	9.22e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.61e-06	9.16e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	5.6e-06	9.15e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PTGS2—type 2 diabetes mellitus	5.59e-06	9.13e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—INS—type 2 diabetes mellitus	5.56e-06	9.08e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PPARA—type 2 diabetes mellitus	5.54e-06	9.05e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PCK1—type 2 diabetes mellitus	5.51e-06	9e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SPRY2—type 2 diabetes mellitus	5.44e-06	8.89e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	5.43e-06	8.86e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	5.4e-06	8.81e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	5.38e-06	8.79e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—AGT—type 2 diabetes mellitus	5.36e-06	8.76e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ALB—type 2 diabetes mellitus	5.34e-06	8.72e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP1A2—type 2 diabetes mellitus	5.32e-06	8.69e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	5.32e-06	8.69e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RBP4—type 2 diabetes mellitus	5.31e-06	8.67e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	5.29e-06	8.65e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	5.29e-06	8.64e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CALM1—type 2 diabetes mellitus	5.27e-06	8.61e-05	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.27e-06	8.61e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—APOE—type 2 diabetes mellitus	5.26e-06	8.58e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—APOA1—type 2 diabetes mellitus	5.2e-06	8.49e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	5.19e-06	8.47e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HK1—type 2 diabetes mellitus	5.16e-06	8.43e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.16e-06	8.43e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	5.16e-06	8.42e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.11e-06	8.34e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—NOS3—type 2 diabetes mellitus	5.11e-06	8.34e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GCG—type 2 diabetes mellitus	5.1e-06	8.33e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	5.1e-06	8.33e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ALB—type 2 diabetes mellitus	5.09e-06	8.32e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	5.04e-06	8.23e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HSD3B2—type 2 diabetes mellitus	4.99e-06	8.14e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—LPA—type 2 diabetes mellitus	4.99e-06	8.14e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—KCNJ11—type 2 diabetes mellitus	4.99e-06	8.14e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GCKR—type 2 diabetes mellitus	4.99e-06	8.14e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SLC2A2—type 2 diabetes mellitus	4.95e-06	8.09e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—NOS3—type 2 diabetes mellitus	4.87e-06	7.96e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PIK3R1—type 2 diabetes mellitus	4.87e-06	7.96e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MTR—type 2 diabetes mellitus	4.85e-06	7.93e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	4.79e-06	7.83e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALDOB—type 2 diabetes mellitus	4.78e-06	7.81e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NAMPT—type 2 diabetes mellitus	4.76e-06	7.77e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—GCK—type 2 diabetes mellitus	4.73e-06	7.72e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IAPP—type 2 diabetes mellitus	4.7e-06	7.68e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PTGS2—type 2 diabetes mellitus	4.67e-06	7.63e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	4.64e-06	7.58e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SLC9A1—type 2 diabetes mellitus	4.62e-06	7.54e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PPARG—type 2 diabetes mellitus	4.58e-06	7.48e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	4.55e-06	7.43e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	4.5e-06	7.34e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—INS—type 2 diabetes mellitus	4.49e-06	7.33e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PTGS2—type 2 diabetes mellitus	4.46e-06	7.28e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GLP1R—type 2 diabetes mellitus	4.44e-06	7.26e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GNB3—type 2 diabetes mellitus	4.4e-06	7.18e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.4e-06	7.18e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—HMOX1—type 2 diabetes mellitus	4.38e-06	7.15e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HMGA1—type 2 diabetes mellitus	4.33e-06	7.06e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CAT—type 2 diabetes mellitus	4.32e-06	7.05e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PSMD6—type 2 diabetes mellitus	4.24e-06	6.93e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SNAP25—type 2 diabetes mellitus	4.24e-06	6.93e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—APOB—type 2 diabetes mellitus	4.19e-06	6.85e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SLC2A2—type 2 diabetes mellitus	4.15e-06	6.78e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ALB—type 2 diabetes mellitus	4.12e-06	6.72e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CYBA—type 2 diabetes mellitus	4.11e-06	6.71e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GSTM1—type 2 diabetes mellitus	4.08e-06	6.66e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CPT1A—type 2 diabetes mellitus	4.06e-06	6.64e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—MTR—type 2 diabetes mellitus	4.06e-06	6.64e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—LPL—type 2 diabetes mellitus	4e-06	6.54e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NAMPT—type 2 diabetes mellitus	3.99e-06	6.51e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CALCA—type 2 diabetes mellitus	3.97e-06	6.49e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.96e-06	6.47e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—LIPC—type 2 diabetes mellitus	3.96e-06	6.47e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HBA1—type 2 diabetes mellitus	3.96e-06	6.47e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GCK—type 2 diabetes mellitus	3.96e-06	6.47e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—NOS3—type 2 diabetes mellitus	3.94e-06	6.43e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PIK3R1—type 2 diabetes mellitus	3.94e-06	6.43e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP11A1—type 2 diabetes mellitus	3.94e-06	6.43e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ADCY5—type 2 diabetes mellitus	3.92e-06	6.4e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GPX1—type 2 diabetes mellitus	3.9e-06	6.38e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SLC9A1—type 2 diabetes mellitus	3.87e-06	6.31e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SLC2A1—type 2 diabetes mellitus	3.84e-06	6.27e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CETP—type 2 diabetes mellitus	3.82e-06	6.24e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CD36—type 2 diabetes mellitus	3.8e-06	6.21e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NOS1—type 2 diabetes mellitus	3.78e-06	6.17e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.75e-06	6.13e-05	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	3.75e-06	6.13e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TCF7L2—type 2 diabetes mellitus	3.74e-06	6.11e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SLC2A4—type 2 diabetes mellitus	3.68e-06	6.01e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.6e-06	5.89e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PTGS2—type 2 diabetes mellitus	3.6e-06	5.88e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.56e-06	5.82e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PSMD6—type 2 diabetes mellitus	3.55e-06	5.8e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SREBF1—type 2 diabetes mellitus	3.55e-06	5.8e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SNAP25—type 2 diabetes mellitus	3.55e-06	5.8e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PPARA—type 2 diabetes mellitus	3.54e-06	5.77e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CTGF—type 2 diabetes mellitus	3.49e-06	5.69e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HMGCR—type 2 diabetes mellitus	3.46e-06	5.64e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—AGT—type 2 diabetes mellitus	3.42e-06	5.59e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.41e-06	5.57e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ADRA2A—type 2 diabetes mellitus	3.38e-06	5.52e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CALM1—type 2 diabetes mellitus	3.37e-06	5.5e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—APOE—type 2 diabetes mellitus	3.35e-06	5.48e-05	CbGpPWpGaD
Bumetanide—CA14—Metabolism—AKT1—type 2 diabetes mellitus	3.33e-06	5.44e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—APOA1—type 2 diabetes mellitus	3.32e-06	5.42e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.25e-06	5.31e-05	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—AKT1—type 2 diabetes mellitus	3.25e-06	5.3e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	3.21e-06	5.25e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.21e-06	5.25e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	3.2e-06	5.23e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.13e-06	5.12e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	3.1e-06	5.06e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.08e-06	5.03e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	3.08e-06	5.03e-05	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—AKT1—type 2 diabetes mellitus	3.03e-06	4.95e-05	CbGpPWpGaD
Bumetanide—CA7—Metabolism—AKT1—type 2 diabetes mellitus	3.03e-06	4.95e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—APOB—type 2 diabetes mellitus	3.02e-06	4.94e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.92e-06	4.77e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—LPL—type 2 diabetes mellitus	2.89e-06	4.71e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—INS—type 2 diabetes mellitus	2.87e-06	4.68e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	2.83e-06	4.61e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—AKT1—type 2 diabetes mellitus	2.81e-06	4.59e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	2.71e-06	4.42e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CCR5—type 2 diabetes mellitus	2.66e-06	4.34e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	2.65e-06	4.34e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.65e-06	4.34e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	2.64e-06	4.32e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ALB—type 2 diabetes mellitus	2.63e-06	4.29e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	2.61e-06	4.26e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	2.6e-06	4.24e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	2.53e-06	4.13e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.51e-06	4.1e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.51e-06	4.1e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	2.48e-06	4.05e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IRS2—type 2 diabetes mellitus	2.47e-06	4.04e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	2.46e-06	4.02e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CALM1—type 2 diabetes mellitus	2.43e-06	3.96e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—APOE—type 2 diabetes mellitus	2.42e-06	3.95e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	2.42e-06	3.95e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—APOA1—type 2 diabetes mellitus	2.39e-06	3.91e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	2.37e-06	3.86e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	2.36e-06	3.85e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—AKT1—type 2 diabetes mellitus	2.35e-06	3.83e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.3e-06	3.75e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	2.3e-06	3.75e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.27e-06	3.7e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NOS2—type 2 diabetes mellitus	2.25e-06	3.68e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—AKT1—type 2 diabetes mellitus	2.24e-06	3.66e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	2.18e-06	3.55e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IRS1—type 2 diabetes mellitus	2.16e-06	3.52e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	2.13e-06	3.49e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	2.07e-06	3.38e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—INS—type 2 diabetes mellitus	2.07e-06	3.38e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	2.03e-06	3.32e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	2.03e-06	3.31e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	2e-06	3.27e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—AKT2—type 2 diabetes mellitus	2e-06	3.26e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	1.9e-06	3.1e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NOS3—type 2 diabetes mellitus	1.81e-06	2.96e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	1.81e-06	2.96e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—AKT1—type 2 diabetes mellitus	1.81e-06	2.96e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	1.76e-06	2.88e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—INS—type 2 diabetes mellitus	1.73e-06	2.83e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	1.59e-06	2.59e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.52e-06	2.48e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	1.52e-06	2.48e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SRC—type 2 diabetes mellitus	1.34e-06	2.19e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	1.2e-06	1.96e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—EGFR—type 2 diabetes mellitus	1.17e-06	1.92e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.16e-06	1.89e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IL6—type 2 diabetes mellitus	9.03e-07	1.47e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—AKT1—type 2 diabetes mellitus	8.33e-07	1.36e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	6.98e-07	1.14e-05	CbGpPWpGaD
